Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.

  • Gunnar Juliusson
  • R Billstrom
  • A Gruber
  • E Hellstrom-Lindberg
  • M Hoglund
  • K Karlsson
  • D Stockelberg
  • A Wahlin
  • M Astrom
  • C Arnesson
  • U Brunell-Abrahamsson
  • J Carstensen
  • E Fredriksson
  • E Holmberg
  • K Nordenskjold
  • F Wiklund
Publiceringsår: 2006
Språk: Engelska
Sidor: 42-47
Publikation/Tidskrift/Serie: Leukemia
Volym: 20
Nummer: 1
Dokumenttyp: Artikel i tidskrift
Förlag: Nature Publishing Group


Combination chemotherapy may induce remission from acute myeloid leukemia (AML), but validated criteria for treatment of elderly are lacking. The remission intention ( RI) rate for elderly patients, as reported to the Swedish Leukemia Registry, was known to be different when comparing the six health care regions, but the consequences of different management are unknown. The Leukemia Registry, containing 1672 AML patients diagnosed between 1997 and 2001, with 98% coverage and a median follow-up of 4 years, was completed with data from the compulsory cancer and population registries. Among 506 treated and untreated patients aged 70-79 years with AML (non-APL), there was a direct correlation between the RI rate in each health region ( range 36-76%) and the two-year overall survival, with no censored observations (6-21%) ( v 2 for trend = 11.3, P < 0.001; r(2) = 0.86, P < 0.02, nonparametric). A 1-month landmark analysis showed significantly better survival in regions with higher RI rates ( P = 0.003). Differences could not be explained by demographics, and was found in both de novo and secondary leukemias. The 5-year survival of the overall population aged 70-79 years was similar between the regions. Survival of 70-79-year-old AML patients is better in regions where more elderly patients are judged eligible for remission induction.


  • Cancer and Oncology
  • acute myeloid leukemia
  • elderly
  • remission induction
  • population based
  • palliation


  • ISSN: 1476-5551

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen